Back to companies

Arrowhead Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Arrowhead Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Arrowhead Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Christopher Anzalone, PhD

President; Chief Executive Officer; Chairman Executive Board Since: 2007 Age: 55

Daniel Apel

Chief Financial Officer Senior Management Since: 2025

Patrick O’Brien

General Counsel; Chief Operating Officer Senior Management Since: 2022 Age: 61

James Hamilton, MD

Chief Medical Officer; Chief - Discovery and Translational Medicine Senior Management Since: 2025 Age: 47

Andy Davis

Head - Metabolic Franchise; Senior Vice President - Cardiovascular Senior Management Since: 2023
Gain a 360-degree view of Arrowhead Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Arrowhead Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer